Nonclinical toxicity studies of antiviral drugs indicated for the treatment of non-life-threatening diseases: Evaluation of drug toxicity prior to phase 1 clinical studies-Reference-Cited by-同舟云学术

Nonclinical toxicity studies of antiviral drugs indicated for the treatment of non-life-threatening diseases: Evaluation of drug toxicity prior to phase 1 clinical studies

Published:1990-02 Issue:1 Volume:11 Page:81-89
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Hoyle Peter C.,Cooper Ellen C.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference3 articles.

1. Reference Guide for the Nonclinical Toxicity Studies of Antiviral Drugs Indicated for the Treatment of Non-Life-Threatening Diseases: Evaluation of Drug Toxicity prior to Phase 1 Clinical Studies;Hoyle,1989

2. Reference Guide for the Nonclinical Toxicity Studies of Drugs Indicated for the Treatment of AIDS and AIDS-Related Diseases: Evaluation of Drug Toxicity prior to Phase 1 Clinical Studies;Hoyle,1989

3. Methods evaluation: Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice;Luster;Fundam. Appl. Toxicol.,1988

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotoxicology: Hazard Identification and Risk Assessment;Nutrition Reviews;2009-04-27

2. The IND Process for New Drug Products;Clinical Drug Trials And Tribulations, Revised And Expanded;2002-03-26

3. The use of animal tests in risk assessment for immunotoxicology;Toxicology in Vitro;1994-10

4. Use of animal studies in risk assessment for immunotoxicology;Toxicology;1994-09

5. CHEMICAL-AGENTS AND THE IMMUNE-RESPONSE;ENVIRON HEALTH PERSP;1993